0000950170-24-076400.txt : 20240621
0000950170-24-076400.hdr.sgml : 20240621
20240621181253
ACCESSION NUMBER: 0000950170-24-076400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240621
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Duncan Barbara Gayle
CENTRAL INDEX KEY: 0001353128
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39661
FILM NUMBER: 241061639
MAIL ADDRESS:
STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC.
STREET 2: 18 DESBROSSES STREET
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atea Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001593899
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 460574869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 857-204-8109
MAIL ADDRESS:
STREET 1: 225 FRANKLIN STREET
STREET 2: SUITE 2100
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
ownership.xml
4
X0508
4
2024-06-21
0001593899
Atea Pharmaceuticals, Inc.
AVIR
0001353128
Duncan Barbara Gayle
225 FRANKLIN STREET
SUITE 2100
BOSTON
MA
02110
true
false
false
false
false
Restricted Stock Units
2024-06-21
4
A
false
29600
0.00
A
Common Stock
29600
29600
D
Stock Option (Right to Buy)
3.44
2024-06-21
4
A
false
41200
0.00
A
2034-06-20
Common Stock
41200
41200
D
Restricted stock units convert into common stock on a one-for-one basis.
The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
/s/ Andrea Corcoran, as Attorney-in-Fact for Barbara Gayle Duncan
2024-06-21